Table 1.
Characteristics of women with prevalent HIV infection not using ART at enrollment, by contraceptive method selected.
| COCs (N=183) | DMPA (N=87) | Nonhormonala (N=156) | |
|---|---|---|---|
| Enrollment CD4 count (cells/mm3): median, IQRb | 545, 342–753 | 606, 379–807 | 456, 319–599 |
| Enrollment log10 HIV RNA: median, IQRb | 3, 2–4 | 3, −1 −3 | 4, 3–4 |
| Previously used ARTc | 76 (41.5) | 58 (66.7) | 41 (26.3) |
| Use of ART within the past monthc,d | 51 (27.9) | 43 (49.4) | 11 (7.0) |
| Time since HIV diagnosisc | |||
| <1 year | 74 (40.4) | 33 (37.9) | 40 (25.6) |
| 1–2 years | 28 (15.3) | 16 (18.4) | 28 (18.0) |
| >2 years | 81 (44.3) | 38 (43.7) | 88 (56.4) |
| Age (years) | |||
| 16–24 | 67 (36.6) | 33 (37.9) | 50 (32.1) |
| 25–29 | 84 (45.9) | 30 (34.5) | 68 (43.6) |
| 30–45 | 32 (17.5) | 24 (27.6) | 38 (24.4) |
| Married or nonmarital union | 149 (81.4) | 71 (81.6) | 131 (84.0) |
| Previous abortionc | |||
| Yes | 105 (57.4) | 55 (63.2) | 98 (62.8) |
| No | 51 (27.9) | 31 (35.6) | 45 (28.9) |
| Never pregnant | 27 (14.8) | 1 (1.2) | 13 (8.3) |
| Previous live births c | |||
| 0 | 53 (29.0) | 4 (4.6) | 40 (25.6) |
| 1 | 102 (55.7) | 50 (57.5) | 91 (58.3) |
| ≥2 | 28 (15.3) | 33 (37.9) | 25 (16.0) |
| Postpartum (≤6 weeks)c | 85 (46.5) | 54 (62.1) | 36 (23.1) |
| Prior hormonal contraception usec | 73 (39.9) | 33 (37.9) | 32 (20.5) |
| Frequency of condom usec | |||
| Always | 61 (33.3) | 15 (17.2) | 81 (51.9) |
| Rarely/sometimes/almost always | 99 (54.1) | 57 (65.5) | 70 (44.9) |
| Never | 23 (12.6) | 15 (17.2) | 5 (3.2) |
| Multiple partners in previous year | 18 (9.8) | 9 (10.3) | 16 (10.3) |
| Positive STD test at enrollmentc,e | 12 (6.6) | 11 (12.6) | 5 (3.2) |
| Use of intravenous drugs in the past 3 monthsc | 6 (3.3) | 15 (17.2) | 5 (4.1) |
Data are shown as number (percentage) unless otherwise indicated.
ART, antiretroviral therapy; IQR, interquartile range.
a
Includes participants choosing the copper IUD (n=33) and condoms (n=123).
b
p<.05, Wilcoxon rank sum test.
c
p<.05, chi-squared test.
d
Data on timing of ART use missing for n=17 (COC), n=12 (DMPA) and n=17 (nonhormonal).
e
Chlamydia or gonorrhea.